Fig. 5.
![Fig. 5. Comparative cytotoxicity of tachpyr and Fe[tachpyr]Cl2. MBT2 cells were treated for 72 hours with either tachpyr (▩) or Fe[tachpyr]Cl2 (▨) before viability was assessed using an MTT assay.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/92/4/10.1182_blood.v92.4.1384/5/blod41630005x.jpeg?Expires=1722789204&Signature=LI6xarY2~xNTtghLtzTt7vf4X52zh5P2i3wIPLIOQyrAfctj5bQHR8h7ZRdMDoxJbHbJzt32G4AYDL0DTeHH9Xw1lKOJOfDHvwP2fg~4kUEdbeXwpBileMTyw4kIQtx8SvSNgVredxCExivlwdM9hYbjGPy2Wxx5fkDa7XfPs4IIx6kk6Dtna0b2whythSsqw~bKEh8t-fyvSxvTCRvuUpOXSPG7~X9lvP877N0A1HQLA-GS-K7GSDun21A7u~h6mN54DSf1ThkGymvwA1wuyC-x-3i6kIpAkZBdVhp8~vu9PTv4P9HrsJu0nl4Bnc~PYZGv~sJlqIcW3Q04xWYnzQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparative cytotoxicity of tachpyr and Fe[tachpyr]Cl2. MBT2 cells were treated for 72 hours with either tachpyr (▩) or Fe[tachpyr]Cl2 (▨) before viability was assessed using an MTT assay.
Comparative cytotoxicity of tachpyr and Fe[tachpyr]Cl2. MBT2 cells were treated for 72 hours with either tachpyr (▩) or Fe[tachpyr]Cl2 (▨) before viability was assessed using an MTT assay.
